Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06888063
What this trial is testing

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

Who this might be right for
Intrahepatic Bile Duct CancerIntrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Carcinoma+1 more
Erasmus Medical Center 40
Not applicableStudy completedNCT03405909
What this trial is testing

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, IntrahepaticLiver Cirrhosis+3 more
University Hospital Erlangen 517
Early research (Phase 1)Study completedNCT05411133
What this trial is testing

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Who this might be right for
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd 33
Testing effectiveness (Phase 2)WithdrawnNCT00386516
What this trial is testing

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Who this might be right for
Cancer of the Bile DuctGallbladder Cancer
Galectin Therapeutics Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07146646
What this trial is testing

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract NeoplasmsCholangiocarcinoma+2 more
Case Comprehensive Cancer Center 27
Not applicableStudy completedNCT03644173
What this trial is testing

Personal Resilience Empowerment Program Study

Who this might be right for
Lung CancerCholangiocarcinomaPancreatic Cancer+1 more
Hackensack Meridian Health 37
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Not applicableUnknownNCT03475966
What this trial is testing

Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program

Who this might be right for
Pancreatic CancerLiver CancerBile Duct Cancer+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 60
Not applicableUnknownNCT04305288
What this trial is testing

Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma of the Bile Duct
Shanghai Jiao Tong University School of Medicine 100
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Large-scale testing (Phase 3)Looking for participantsNCT05342194
What this trial is testing

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Looking for participantsNCT05874414
What this trial is testing

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Genfit 98
Testing effectiveness (Phase 2)Looking for participantsNCT06199895
What this trial is testing

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Who this might be right for
Pancreatic AdenocarcinomaCholangiocarcinomaLung Cancer+3 more
Liu Huang 25
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Testing effectiveness (Phase 2)UnknownNCT04782804
What this trial is testing

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Fudan University 30
Not applicableUnknownNCT05634694
What this trial is testing

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

Who this might be right for
Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Testing effectiveness (Phase 2)Ended earlyNCT02150967
What this trial is testing

A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma

Who this might be right for
Advanced CholangiocarcinomaFGFR2 Gene Mutation
QED Therapeutics, a BridgeBio company 143
Not applicableLooking for participantsNCT03445585
What this trial is testing

Biobank for Cholestatic Liver Diseases.

Who this might be right for
Primary Sclerosing CholangitisPrimary Biliary CirrhosisCholangiocarcinoma+1 more
Mayo Clinic 9,150
Large-scale testing (Phase 3)Ended earlyNCT02807181
What this trial is testing

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sirtex Medical 89
Next Page